IRIS
PIRISI, Mario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 15.137
NA - Nord America 12.130
AS - Asia 9.112
SA - Sud America 1.500
AF - Africa 363
Continente sconosciuto - Info sul continente non disponibili 25
OC - Oceania 20
AN - Antartide 1
Totale 38.288
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.762
RU - Federazione Russa 3.883
SG - Singapore 2.829
IE - Irlanda 2.783
CN - Cina 1.915
IT - Italia 1.803
DE - Germania 1.650
HK - Hong Kong 1.404
SE - Svezia 1.316
VN - Vietnam 1.304
FR - Francia 1.197
BR - Brasile 1.128
UA - Ucraina 944
IN - India 514
FI - Finlandia 493
GB - Regno Unito 360
KR - Corea 249
CA - Canada 216
AR - Argentina 156
ID - Indonesia 141
BJ - Benin 139
CZ - Repubblica Ceca 137
PL - Polonia 117
MX - Messico 110
TR - Turchia 108
AT - Austria 103
BD - Bangladesh 102
NL - Olanda 90
ZA - Sudafrica 87
JP - Giappone 83
IQ - Iraq 78
ES - Italia 76
IR - Iran 61
BE - Belgio 49
EC - Ecuador 46
PK - Pakistan 45
CL - Cile 44
VE - Venezuela 36
LT - Lituania 35
CO - Colombia 34
PH - Filippine 29
EG - Egitto 28
MA - Marocco 24
TH - Thailandia 24
SA - Arabia Saudita 23
TW - Taiwan 22
PE - Perù 21
EU - Europa 20
PY - Paraguay 20
UZ - Uzbekistan 19
CH - Svizzera 18
MY - Malesia 18
AU - Australia 17
KE - Kenya 17
JO - Giordania 16
TN - Tunisia 16
NP - Nepal 15
AE - Emirati Arabi Uniti 14
IL - Israele 14
DZ - Algeria 13
RO - Romania 12
AL - Albania 10
AZ - Azerbaigian 9
DO - Repubblica Dominicana 9
NG - Nigeria 9
PT - Portogallo 9
KZ - Kazakistan 8
LB - Libano 8
OM - Oman 8
UY - Uruguay 8
BH - Bahrain 7
RS - Serbia 7
SN - Senegal 7
ET - Etiopia 5
GE - Georgia 5
GT - Guatemala 5
JM - Giamaica 5
LV - Lettonia 5
SY - Repubblica araba siriana 5
TT - Trinidad e Tobago 5
BO - Bolivia 4
BY - Bielorussia 4
HR - Croazia 4
LK - Sri Lanka 4
MN - Mongolia 4
MO - Macao, regione amministrativa speciale della Cina 4
PS - Palestinian Territory 4
XK - ???statistics.table.value.countryCode.XK??? 4
AM - Armenia 3
BA - Bosnia-Erzegovina 3
CR - Costa Rica 3
DK - Danimarca 3
GR - Grecia 3
HN - Honduras 3
KG - Kirghizistan 3
LY - Libia 3
MK - Macedonia 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PA - Panama 3
Totale 38.229
Salva come PNG Salva come JPEG
Città #
Dublin 2.764
Jacksonville 1.659
Hong Kong 1.384
San Jose 1.321
Singapore 1.087
Ashburn 911
Dearborn 733
Beijing 621
Chandler 603
Moscow 446
Wilmington 431
Ho Chi Minh City 393
Lauterbourg 361
Los Angeles 355
Novara 344
Princeton 333
Lawrence 332
Hanoi 282
San Mateo 252
Ann Arbor 241
Munich 224
Piemonte 216
Buffalo 215
Seoul 207
New York 188
Milan 175
São Paulo 147
Cotonou 139
Andover 130
Orem 122
Houston 120
Council Bluffs 114
Frankfurt am Main 112
Boardman 108
Santa Clara 108
Turin 101
Dallas 96
Jakarta 91
Warsaw 91
Helsinki 90
Chennai 89
Nuremberg 85
Brno 73
Montreal 72
Denver 71
Vercelli 71
Woodbridge 71
London 69
Brooklyn 66
Redondo Beach 66
Bremen 65
Guangzhou 63
Tokyo 63
Nanjing 62
Poplar 61
Dong Ket 60
Falkenstein 60
Johannesburg 60
Toronto 55
Da Nang 54
Turku 53
Hefei 52
Tianjin 52
Atlanta 51
Stockholm 50
Brussels 47
Vienna 46
Amsterdam 45
Philadelphia 45
Mexico City 43
Phoenix 43
Boston 42
Haiphong 42
Mumbai 40
Seattle 39
Shanghai 38
Ankara 37
Chicago 37
Düsseldorf 37
Rome 37
Pardubice 34
Hangzhou 33
Norwalk 33
Manchester 31
Biên Hòa 29
Kunming 29
Rio de Janeiro 28
Hải Dương 27
Kocaeli 27
Baghdad 25
Hillsboro 25
Dhaka 24
Paris 24
The Dalles 23
Torino 23
Brasília 22
Curitiba 22
Mülheim 22
Jinan 21
Querétaro 21
Totale 20.382
Salva come PNG Salva come JPEG
Nome #
Midterm functional sequelae and implications in rehabilitation after COVID19. A cross-sectional study 371
Expression of the interferon-inducible proteins MxA and IFI16 in liver allografts 275
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 248
Genetic polymorphisms of inflammatory cytokines and liver fibrosis progression due to recurrent hepatitis C 225
Genistein and 17β-Estradiol Protect Hepatocytes from Fatty Degeneration by Mechanisms Involving Mitochondria, Inflammasome and Kinases Activation 213
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 190
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 174
Liver infection and COVID-19: the electron microscopy proof and revision of the literature 169
Ongoing Mycophenolate Treatment Impairs Anti-SARS-CoV-2 Vaccination Response in Patients Affected by Chronic Inflammatory Autoimmune Diseases or Liver Transplantation Recipients: Results of the RIVALSA Prospective Cohort 164
Gas6 as a predictor of esophageal varices in patients affected by hepatitis C virus related-chronic liver disease 164
Testosterone Plasma Concentration is Associated with Insulin Resistance in Male Hypertensive Patients 164
Change over time of COVID-19 hospital presentation in Northern Italy 162
Clinical Relevance of Liver Involvement in the Clinical Course of Systemic Sclerosis 160
Response rates to direct antiviral agents among hepatitis C virus infected patients who develop hepatocellular carcinoma following direct antiviral agents treatment 156
On-target sorafenib toxicity predicts improved survival in hepatocellular carcinoma: a multi-centre, prospective study 155
Association between red cell distribution width and response to methotrexate in rheumatoid arthritis 155
Clinical outcome with different doses of low-molecular-weight heparin in patients hospitalized for COVID-19 155
Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge 155
rs1801253 Gly/Gly carriage in the ADRB1 gene leads to unbalanced cardiac sympathetic modulation as assessed by spectral analysis of heart rate variability 154
Relation among anti-rheumatic drug therapy, CD14(+)CD16(+) blood monocytes and disease activity markers (DAS28 and US7 scores) in rheumatoid arthritis: A pilot study. 153
Role of positron emission tomography in the assessment of disease burden and risk of relapse in patients affected by giant cell arteritis 153
Effect of Lactoferrin on Clinical Outcomes of Hospitalized Patients with COVID-19: The LAC Randomized Clinical Trial 152
Treatment failure after interferon-free treatment of hepatitis C as a clue of a yet undetected hepatocellular carcinoma 152
Levosimendan inhibits peroxidation in hepatocytes by modulating apoptosis/autophagy interplay. 152
B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD) 152
Mid-term Psychiatric Outcomes of Patients Recovered From COVID-19 From an Italian Cohort of Hospitalized Patients 149
CGRP Plasma Levels Correlate with the Clinical Evolution and Prognosis of Hospitalized Acute COVID-19 Patients 146
Role of beta-blockers in patients with COPD: current perspective. 146
Outcomes of COVID-19 patients treated with continuous positive airway pressure outside ICU 144
Acute decompensated heart failure in the emergency department: Identification of early predictors of outcome 143
Prognostic Markers in Hospitalized COVID-19 Patients: The Role of IP-10 and C-Reactive Protein 143
Pattern of emergency department referral during the Covid-19 outbreak in Italy 142
Long-term sequelae are highly prevalent one year after hospitalization for severe COVID-19 141
Altered glucose metabolism rather than naive type 2 diabetes mellitus (T2DM) is related to vitamin D status in severe obesity. 140
Association between rheumatic diseases and cancer: results from a clinical practice cohort study 139
Inflammatory markers predict insulin sensitivity in active rheumatoid arthritis but not in psoriatic arthritis 139
Antiviral treatment of hepatitis C improves glucose metabolism along the entire spectrum from normal glucose tolerance to diabetes 139
Is cholecalciferol a potential disease modifying anti-rheumatic drug for the management of rheumatoid arthritis? 139
Determinants of long COVID among adults hospitalized for SARS-CoV-2 infection: A prospective cohort study 137
One-Year Follow up of Noninvasive Respiratory Support in General Wards 137
Vitamin D in Systemic Sclerosis: A Review 136
"war to the knife" against thromboinflammation to protect endothelial function of COVID-19 patients 136
Interplay of PNPLA3 and HSD17B13 Variants in Modulating the Risk of Hepatocellular Carcinoma among Hepatitis C Patients 136
Analysis of beta1 and beta2-adrenergic receptors polymorphism in patients with apical ballooning cardiomyopathy 135
SARS-CoV-2 infection risk is higher in vaccinated patients with inflammatory autoimmune diseases or liver transplantation treated with mycophenolate due to an impaired antiviral immune response: results of the extended follow up of the RIVALSA prospective cohort 134
Validation of the Hepatoma Arterial Embolization Prognostic Score in European and Asian Populations and Proposed Modification. 134
L’impatto del Long COVID è stato minore nella terza ondata della pandemia rispetto alla prima ondata in una popolazione italiana di 324 pazienti. 133
Integration of the cancer-related inflammatory response as a stratifying biomarker of survival in hepatocellular carcinoma treated with sorafenib 133
Role of Osteopontin as a Potential Biomarker of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis and Other Connective Tissue Diseases (CTDs) 133
Baseline Plasma Osteopontin Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients 132
Identification of mutations in circulating cell-free tumour DNA as a biomarker in hepatocellular carcinoma 132
Decreased Gas6 and sAxl Plasma Levels Are Associated with Hair Loss in COVID-19 Survivors 131
Evaluation of the red cell distribution width as a biomarker of early mortality in hepatocellular carcinoma 131
Baseline Plasma Gas6 Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients 131
Gas6/TAM system: A key modulator of the interplay between inflammation and fibrosis 130
Combined sequential use of HAP and ART scores to predict survival outcome and treatment failure following chemoembolization in hepatocellular carcinoma: A multi-center comparative study 129
Anxiety, Stress and Depression in COVID-19 Survivors From an Italian Cohort of Hospitalized Patients: Results From a 1-Year Follow-Up 127
Red cell distribution width and platelet count as biomarkers of pulmonary arterial hypertension in patients with connective tissue disorders 127
Detrimental Impact of Interferon-Based Regimens for Chronic Hepatitis C on Vitamin D/Parathyroid Hormone Homeostasis 127
17,β-estradiol inhibits hepatitis C virus mainly by interference with the release phase of its life cycle 126
Oxidative Stress in Non-Alcoholic Fatty Liver Disease 126
Anti-envelope antibodies in anti-hepatitis C virus (HCV) positive patients with and without liver disease 125
4. Association between release of tumor necrosis factor and response to interferon therapy in chronic hepatitis C 125
First reported human case of meningitis by Staphylococcus condimenti 125
A 28-Year-Old Woman with Ascites and Multiple Focal Spleen Lesions 124
Improvement of insulin sensitivity in diabetic and non diabetic patients with chronic hepatitis C treated with direct antiviral agents 123
AORTIC INVOLVEMENT IN A RETROSPECTIVE COHORT OF LARGE VESSEL VASCULITIS PATIENTS 123
Increased Levels of ICOS and ICOSL Are Associated to Pulmonary Arterial Hypertension in Patients Affected by Connective Tissue Diseases 123
17β-Oestradiol Protects from Hepatitis C Virus Infection through Induction of Type I Interferon 122
A nurse-led coaching intervention with home telemonitoring for patients with heart failure: Protocol for a feasibility randomized clinical trial 122
Diagnostic value of FibroTest with normal serum aminotransferases 122
An unusual adverse reaction to iodine-based contrast agent. 122
Understanding protection from SARS-CoV-2 using metabolomics 122
Interaction between thrombin potential and age on early clinical outcome in patients hospitalized for COVID-19 122
Influence of age on sex-related differences among patients with hepatitis C. 120
Gas6 as a putative noninvasive biomarker of hepatic fibrosis 120
Profiling the patients visiting the emergency room for musculoskeletal complaints: characteristics and outcomes 118
Recent advances in the pathophysiology, diagnosis and treatment of hereditary hemochromatosis and other iron overload syndromes 118
Presenting features and early mortality from SARS-CoV-2 infection in cancer patients during the initial stage of the COVID-19 pandemic in Europe 118
(Letter) Membranoproliferative glomerulonephritis associated with Hepatitis C infection with no evidence of liver disease 117
Ultrasound-assessed visceral fat and associations with glucose homeostasis and cardiovascular risk in clinical practice 117
Baseline plasma SARS-CoV-2 RNA detection predicts an adverse COVID-19 evolution in moderate to severe hospitalized patients 116
A woman with anemia and a small bowel obstruction 116
Increased plasma levels of Gas6 and its soluble tyrosine kinase receptors Mer and Axl are associated with immunological activity and severity of lupus nephritis 116
Gas6/TAM system as potential biomarker for multiple sclerosis prognosis 115
A case of false positive troponin I in a patient affected by cryoglobulinemic vasculitis 115
A rare cause of intractable diarrhea 115
Liver stiffness, not fat liver content, predicts the length of QTc interval in patients with chronic liver disease 115
Gas6/TAM system: potential prognostic biomarker for Multiple Sclerosis 114
Cardiopulmonary exercise testing is an accurate tool for the diagnosis of pulmonary arterial hypertension in scleroderma related diseases 114
Asymptomatic HBV and HCV carriers, bad breath and gengivitis 113
Cardiac dysfunction as an early predictor of portal hypertension in chronic hepatitis C 113
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 113
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 113
Hepatic decompensation is the major driver of mortality in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment 112
Significato e valore diagnostico dei sintomi e degli esami di laboratorio 112
APOLIPOPROTEIN E GENOTYPES MODULATE FIBROSIS PROGRESSION IN PATIENTS WITH CHRONIC HEPATITIS C AND PERSISTENTLY NORMAL TRANSAMINASES 112
Eosinophilic gastroenteritis in pregnancy: A review of the literature 112
HSD17B13 and other liver fat-modulating genes predict development of hepatocellular carcinoma among HCV-positive cirrhotics with and without viral clearance after DAA treatment 112
Assessment of liver fibrosis progression in patients with chronic hepatitis C and normal alanine aminotransferase values: the role of the AST to platelet ratio index 111
Totale 13.993
Salva come PNG Salva come JPEG
Categoria #
all - tutte 186.587
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 186.587
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021552 0 0 0 0 0 0 0 0 0 77 363 112
2021/20222.287 101 58 459 228 112 28 168 80 196 104 284 469
2022/20235.518 502 220 276 151 299 444 165 234 2.846 34 226 121
2023/20242.593 140 341 151 77 394 74 490 134 54 86 249 403
2024/20255.293 135 65 262 144 146 336 525 545 1.202 493 390 1.050
2025/202615.975 780 666 1.148 2.455 1.718 1.243 2.668 2.910 1.270 1.117 0 0
Totale 38.999